A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

NCT06159725 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent Infection
Cystic Fibrosis

Interventions

DRUG: CMTX-101
DRUG: Placebo

Sponsor

Clarametyx Biosciences, Inc.